Jeri Ann Boose, Ph.D. has joined Lancaster Laboratories as director of Biopharmaceutical Services. Dr. Boose will provide strategic, scientific and regulatory direction for the company’s biopharmaceutical testing business, which includes capabilities in the areas of biochemistry, cell and molecular biology and virology.

Dr. Boose has expertise in the formulation of global regulatory product testing strategies and in the preparation of global regulatory filings at all stages of product development, as well as commercialization of new products for biopharmaceutical customers.

“The combination of Dr. Boose’s renowned expertise in biologics, coupled with our comprehensive biopharmaceutical capabilities, clearly positions Lancaster Laboratories as a leading provider of services to support the development and commercialization of biologics products,” says Dr. Timothy S. Oostdyk, executive vice president and chief operating officer of Lancaster Laboratories.

Visit Lancaster Labs at Contracting & Outsourcing 2010!